Intensive Care Unit Care of a Patient with Cirrhosis

References

1. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
   Lancet Gastroenterol Hepatol. 2020; 5: 245-266
   View in Article

   • Google Scholar
2. • Sarin S.K.
   • Kumar M.
   • Eslam M.
   • et al.
   Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.
   Lancet Gastroenterol Hepatol. 2020; 5: 167-228
   View in Article

   • Google Scholar
3. • McPhail M.J.W.
   • Parrott F.
   • Wendon J.A.
   • et al.
   Incidence and Outcomes for Patients With Cirrhosis Admitted to the United Kingdom Critical Care Units.
   Crit Care Med. 2018; 46: 705-712
   View in Article

   • Google Scholar
4. • Warren A.
   • Soulsby C.R.
   • Puxty A.
   • et al.
   Long-term outcome of patients with liver cirrhosis admitted to a general intensive care unit.
   Ann Intensive Care. 2017; 7: 37
   View in Article

   • Google Scholar
5. • Idalsoaga F.
   • Kulkarni A.V.
   • Mousa O.Y.
   • et al.
   Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities.
   Front Med (Lausanne). 2020; 7: 448
   View in Article

   • Google Scholar
6. • Kulkarni A.V.
   • Duvvuru N.R.
   Management of hepatitis B and C in special population.
   World J Gastroenterol. 2021; 27: 6861-6873
   View in Article

   • Google Scholar
7. • Huang Y.-F.
   • Lin C.-S.
   • Cherng Y.-G.
   • et al.
   A population-based cohort study of mortality of intensive care unit patients with liver cirrhosis.
   BMC Gastroenterol. 2020; 20: 15
   View in Article

   • Google Scholar
8. • Passi N.N.
   • McPhail M.J.
   The patient with cirrhosis in the intensive care unit and the management of acute-on-chronic liver failure.
   J Intensive Care Soc. 2022; 23: 78-86
   View in Article

   • Google Scholar
9. • Kubesch A.
   • Peiffer K.H.
   • Abramowski H.
   • et al.
   The presence of liver cirrhosis is a strong negative predictor of survival for patients admitted to the intensive care unit - Cirrhosis in intensive care patients.
   Z Gastroenterol. 2021; 59: 657-664
   View in Article

   • Google Scholar
10. • Moreau R.
    • Jalan R.
    • Gines P.
    • et al.
    Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
    Gastroenterology. 2013; 144 (37.e1-9): 1426-1437
    View in Article

    • Google Scholar
11. • Sarin S.K.
    • Choudhury A.
    • Sharma M.K.
    • et al.
    Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.
    Hepatol Int. 2019; 13: 353-390
    View in Article

    • Google Scholar
12. • Hernaez R.
    • Solà E.
    • Moreau R.
    • et al.
    Acute-on-chronic liver failure: an update.
    Gut. 2017; 66: 541-553
    View in Article

    • Google Scholar
13. • Dong V.
    • Karvellas C.J.
    Acute-on-chronic liver failure: objective admission and support criteria in the intensive care unit.
    JHEP Rep. 2019; 1: 44-52
    View in Article

    • Google Scholar
14. • Thim T.
    • Krarup N.H.V.
    • Grove E.L.
    • et al.
    Initial assessment and treatment with the airway, breathing, circulation, disability, exposure (ABCDE) approach.
    Int J Gen Med. 2012; 5: 117
    View in Article

    • Google Scholar
15. • Maiwall R.
    • Kumar A.
    • Pasupuleti S.S.R.
    • et al.
    A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial].
    J Hepatol. 2022; 77: 670-682
    View in Article

    • Google Scholar
16. • Guevarra K.
    • Greenstein Y.
    Ultrasonography in the Critical Care Unit.
    Curr Cardiol Rep. 2020; 22: 145
    View in Article

    • Google Scholar
17. • Moore C.L.
    • Copel J.A.
    Point-of-care ultrasonography.
    N Engl J Med. 2011; 364: 749-757
    View in Article

    • Google Scholar
18. • Levitov A.
    • Frankel H.L.
    • Blaivas M.
    • et al.
    Guidelines for the appropriate use of bedside general and cardiac ultrasonography in the evaluation of critically ill patients-part II: cardiac ultrasonography.
    Crit Care Med. 2016; 44: 1206-1227
    View in Article

    • Google Scholar
19. • Kajal K.
    • Premkumar M.
    • Chaluvashetty S.B.
    • et al.
    Point-of-care thoracic ultrasonography in patients with cirrhosis and liver failure.
    Cureus. 2021; 13: e15559
    View in Article

    • Google Scholar
20. • Reynolds A.S.
    • Liang J.
    • Raiss M.
    • et al.
    Fatal cerebral edema in patients with decompensated cirrhosis: a case series.
    J Crit Care. 2021; 61: 115-118
    View in Article

    • Google Scholar
21. • Bennett C.E.
    • Samavedam S.
    • Jayaprakash N.
    • et al.
    When to incorporate point-of-care ultrasound (POCUS) into the initial assessment of acutely ill patients: a pilot crossover study to compare 2 POCUS-assisted simulation protocols.
    Cardiovasc Ultrasound. 2018; 16: 14
    View in Article

    • Google Scholar
22. • Kameda T.
    • Kimura A.
    Basic point-of-care ultrasound framework based on the airway, breathing, and circulation approach for the initial management of shock and dyspnea.
    Acute Med Surg. 2020; 7: e481
    View in Article

    • Google Scholar
23. • Kulkarni A.V.
    • Premkumar M.
    • Arab J.P.
    • et al.
    Early Diagnosis and Prevention of Infections in Cirrhosis.
    Semin Liver Dis. 2022; 42: 293-312
    View in Article

    • Google Scholar
24. • Bonnel A.R.
    • Bunchorntavakul C.
    • Reddy K.R.
    Immune dysfunction and infections in patients with cirrhosis.
    Clin Gastroenterol Hepatol. 2011; 9: 727-738
    View in Article

    • Google Scholar
25. • Bajaj J.S.
    • Kamath P.S.
    • Reddy K.R.
    The Evolving Challenge of Infections in Cirrhosis.
    N Engl J Med. 2021; 384: 2317-2330
    View in Article

    • Google Scholar
26. • Cullaro G.
    • Sharma R.
    • Trebicka J.
    • et al.
    Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes.
    Liver Transpl. 2020; 26: 283-293
    View in Article

    • Google Scholar
27. • Kulkarni A.V.
    • Tirumalle S.
    • Premkumar M.
    • et al.
    Primary norfloxacin prophylaxis for APASl-defined acute-on-chronic liver failure: a placebo-controlled double-blind randomized trial.
    Am J Gastroenterol. 2022; 117: 607-616
    View in Article

    • Google Scholar
28. • Kulkarni A.V.
    • Anand L.
    • Vyas A.K.
    • et al.
    Omega-3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute-on-chronic liver failure: An open-label randomized controlled trial.
    J Gastroenterol Hepatol. 2021; 36: 1953-1961
    View in Article

    • Google Scholar
29. • Gustot T.
    • Durand F.
    • Lebrec D.
    • et al.
    Severe sepsis in cirrhosis.
    Hepatology. 2009; 50: 2022-2033
    View in Article

    • Google Scholar
30. • Bajaj J.S.
    • Reddy R.K.
    • Tandon P.
    • et al.
    Prediction of fungal infection development and their impact on survival using the NACSELD cohort.
    Am J Gastroenterol. 2018; 113: 556-563
    View in Article

    • Google Scholar
31. • Fernández J.
    • Piano S.
    • Bartoletti M.
    • et al.
    Management of bacterial and fungal infections in cirrhosis: The MDRO challenge.
    J Hepatol. 2021; 75 (S101–s107)
    View in Article

    • Google Scholar
32. • Bajaj J.S.
    • O'Leary J.G.
    • Reddy K.R.
    • et al.
    Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.
    Hepatology. 2014; 60: 250-256
    View in Article

    • Google Scholar
33. • Simonetto D.A.
    • Piccolo Serafim L.
    • Gallo de Moraes A.
    • et al.
    Management of sepsis in patients with cirrhosis: current evidence and practical approach.
    Hepatology. 2019; 70: 418-428
    View in Article

    • Google Scholar
34. • Kulkarni A.V.
    • Kumar P.
    • Sharma M.
    • et al.
    Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review.
    J Clin Transl Hepatol. 2020; 8: 42-48
    View in Article

    • Google Scholar
35. • Moreau R.
    • Hadengue A.
    • Soupison T.
    • et al.
    Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome.
    Crit Care Med. 1992; 20: 746-750
    View in Article

    • Google Scholar
36. • Chebl R.B.
    • Tamim H.
    • Sadat M.
    • et al.
    Outcomes of septic cirrhosis patients admitted to the intensive care unit: a retrospective cohort study.
    Medicine (Baltimore). 2021; 100: e27593
    View in Article

    • Google Scholar
37. • Piano S.
    • Bartoletti M.
    • Tonon M.
    • et al.
    Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections.
    Gut. 2018; 67: 1892-1899
    View in Article

    • Google Scholar
38. • Augustinho F.C.
    • Zocche T.L.
    • Borgonovo A.
    • et al.
    Applicability of Sepsis-3 criteria and quick Sequential Organ Failure Assessment in patients with cirrhosis hospitalised for bacterial infections.
    Liver Int. 2019; 39: 307-315
    View in Article

    • Google Scholar
39. • Fernández J.
    • Acevedo J.
    • Wiest R.
    • et al.
    Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis.
    Gut. 2018; 67: 1870-1880
    View in Article

    • Google Scholar
40. • D'Amico G.
    • Garcia-Tsao G.
    • Pagliaro L.
    Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
    J Hepatol. 2006; 44: 217-231
    View in Article

    • Google Scholar
41. • Augustin S.
    • Muntaner L.
    • Altamirano J.T.
    • et al.
    Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis.
    Clin Gastroenterol Hepatol. 2009; 7: 1347-1354
    View in Article

    • Google Scholar
42. • Lee H.
    • Hawker F.H.
    • Selby W.
    • et al.
    Intensive care treatment of patients with bleeding esophageal varices: results, predictors of mortality, and predictors of the adult respiratory distress syndrome.
    Crit Care Med. 1992; 20: 1555-1563
    View in Article

    • Google Scholar
43. • Sarin S.K.
    • Kumar A.
    • Angus P.W.
    • et al.
    Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations.
    Hepatol Int. 2011; 5: 607-624
    View in Article

    • Google Scholar
44. • Kim G.H.
    • Kim J.H.
    • Kim Y.J.
    • et al.
    Value of the APASL severity score in patients with acute variceal bleeding: a single center experience.
    Hepatol Int. 2013; 7: 1058-1064
    View in Article

    • Google Scholar
45. • Reverter E.
    • Tandon P.
    • Augustin S.
    • et al.
    A MELD-based model to determine risk of mortality among patients with acute variceal bleeding.
    Gastroenterology. 2014; 146: 412-419.e3
    View in Article

    • Google Scholar
46. • Mallet M.
    • Rudler M.
    • Thabut D.
    Variceal bleeding in cirrhotic patients.
    Gastroenterol Rep (Oxf). 2017; 5: 185-192
    View in Article

    • Google Scholar
47. • Cárdenas A.
    • Ginès P.
    • Uriz J.
    • et al.
    Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis.
    Hepatology. 2001; 34: 671-676
    View in Article

    • Google Scholar
48. • Villanueva C.
    • Colomo A.
    • Bosch A.
    • et al.
    Transfusion strategies for acute upper gastrointestinal bleeding.
    N Engl J Med. 2013; 368: 11-21
    View in Article

    • Google Scholar
49. • Kulkarni A.V.
    • Rabiee A.
    • Mohanty A.
    Management of Portal Hypertension.
    J Clin Exp Hepatol. 2022; 12: 1184-1199
    View in Article

    • Google Scholar
50. • Chavez-Tapia N.C.
    • Barrientos-Gutierrez T.
    • Tellez-Avila F.I.
    • et al.
    Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.
    Cochrane Database Syst Rev. 2010; 2010: Cd002907
    View in Article

    • Google Scholar
51. • Augustin S.
    • Altamirano J.
    • González A.
    • et al.
    Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding.
    Am J Gastroenterol. 2011; 106: 1787-1795
    View in Article

    • Google Scholar
52. • Seo Y.S.
    • Park S.Y.
    • Kim M.Y.
    • et al.
    Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.
    Hepatology. 2014; 60: 954-963
    View in Article

    • Google Scholar
53. • de Franchis R.
    • Bosch J.
    • Garcia-Tsao G.
    • et al.
    Baveno VII - Renewing consensus in portal hypertension.
    J Hepatol. 2021; 76: 959-974
    View in Article

    • Google Scholar
54. • Lin L.
    • Cui B.
    • Deng Y.
    • et al.
    The Efficacy of Proton Pump Inhibitor in Cirrhotics with Variceal Bleeding: A Systemic Review and Meta-Analysis.
    Digestion. 2021; 102: 117-127
    View in Article

    • Google Scholar
55. • Lau J.Y.W.
    • Yu Y.
    • Tang R.S.Y.
    • et al.
    Timing of endoscopy for acute upper gastrointestinal bleeding.
    N Engl J Med. 2020; 382: 1299-1308
    View in Article

    • Google Scholar
56. • Guo C.L.T.
    • Wong S.H.
    • Lau L.H.S.
    • et al.
    Timing of endoscopy for acute upper gastrointestinal bleeding: a territory-wide cohort study.
    Gut. 2022; 71: 1544-1550
    View in Article

    • Google Scholar
57. • Boike J.R.
    • Thornburg B.G.
    • Asrani S.K.
    • et al.
    North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.
    Clin Gastroenterol Hepatol. 2022; 20 (e36): 1636-1662
    View in Article

    • Google Scholar
58. • Majeed A.
    • Majumdar A.
    • Bailey M.
    • et al.
    Declining mortality of cirrhotic variceal bleeding requiring admission to intensive care: a binational cohort study.
    Crit Care Med. 2019; 47: 1317-1323
    View in Article

    • Google Scholar
59. • Romcea A.A.
    • Tanţău M.
    • Seicean A.
    • et al.
    The etiology of upper gastrointestinal bleeding in cirrhotic patients.
    Clujul Med. 2013; 86: 21-23
    View in Article

    • Google Scholar
60. • Kumar M.
    • Ahmad J.
    • Maiwall R.
    • et al.
    Thromboelastography-Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial.
    Hepatology. 2020; 71: 235-246
    View in Article

    • Google Scholar
61. • Kalafateli M.
    • Triantos C.K.
    • Nikolopoulou V.
    • et al.
    Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review.
    Dig Dis Sci. 2012; 57: 2743-2754
    View in Article

    • Google Scholar
62. • González-González J.A.
    • García-Compean D.
    • Vázquez-Elizondo G.
    • et al.
    Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality. A prospective study.
    Ann Hepatol. 2011; 10: 287-295
    View in Article

    • Google Scholar
63. • Marmo R.
    • Koch M.
    • Cipolletta L.
    • et al.
    Predictive factors of mortality from nonvariceal upper gastrointestinal hemorrhage: a multicenter study.
    Am J Gastroenterol. 2008; 103 ([quiz: 48]): 1639-1647
    View in Article

    • Google Scholar
64. • Stewart C.A.
    • Malinchoc M.
    • Kim W.R.
    • et al.
    Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease.
    Liver Transpl. 2007; 13: 1366-1371
    View in Article

    • Google Scholar
65. • Vilstrup H.
    • Amodio P.
    • Bajaj J.
    • et al.
    Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.
    Hepatology. 2014; 60: 715-735
    View in Article

    • Google Scholar
66. • Fichet J.
    • Mercier E.
    • Genée O.
    • et al.
    Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy.
    J Crit Care. 2009; 24: 364-370
    View in Article

    • Google Scholar
67. • Bajaj J.S.
    • Tandon P.
    • O'Leary J.G.
    • et al.
    Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort.
    Clin Gastroenterol Hepatol. 2022; (S1542-3565(22)00388-00393)
    View in Article

    • Google Scholar
68. • Katsounas A.
    • Canbay A.
    Intensive Care Therapy for Patients with Advanced Liver Diseases.
    Visc Med. 2018; 34: 283-289
    View in Article

    • Google Scholar
69. • Ahmed S.
    • Premkumar M.
    • Dhiman R.K.
    • et al.
    Combined PEG3350 plus lactulose results in early resolution of hepatic encephalopathy and improved 28-day survival in acute-on-chronic liver failure.
    J Clin Gastroenterol. 2022; 56: e11-e19
    View in Article

    • Google Scholar
70. • Montagnese S.
    • Rautou P.-E.
    • Romero-Gómez M.
    • et al.
    EASL clinical practice guidelines on the management of hepatic encephalopathy.
    J Hepatol. 2022; 77: 807-824
    View in Article

    • Google Scholar
71. • Sharma B.C.
    • Sharma P.
    • Lunia M.K.
    • et al.
    A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
    Am J Gastroenterol. 2013; 108: 1458-1463
    View in Article

    • Google Scholar
72. • Jain A.
    • Sharma B.C.
    • Mahajan B.
    • et al.
    L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
    Hepatology. 2021; 75: 1194-1203
    View in Article

    • Google Scholar
73. • Bajaj J.S.
    • Salzman N.H.
    • Acharya C.
    • et al.
    Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial.
    Hepatology. 2019; 70: 1690-1703
    View in Article

    • Google Scholar
74. • Kobashi-Margáin R.
    • Gavilanes-Espinar J.
    • Gutiérrez-Grabe Y.
    • et al.
    Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure.
    Ann Hepatol. 2011; 10: S70-S76
    View in Article

    • Google Scholar
75. • Bañares R.
    • Nevens F.
    • Larsen F.S.
    • et al.
    Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.
    Hepatology. 2013; 57: 1153-1162
    View in Article

    • Google Scholar
76. • Maiwall R.
    • Bajpai M.
    • Singh A.
    • et al.
    Standard-Volume Plasma Exchange Improves Outcomes in Patients With Acute Liver Failure: A Randomized Controlled Trial.
    Clin Gastroenterol Hepatol. 2022; 20: e831-e854
    View in Article

    • Google Scholar
77. • Larsen F.S.
    • Schmidt L.E.
    • Bernsmeier C.
    • et al.
    High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial.
    J Hepatol. 2016; 64: 69-78
    View in Article

    • Google Scholar
78. • Vora M.
    • Kulkarni A.
    • Rakam K.
    • et al.
    Standard volume plasma exchange is safe and effective for patients with acute liver failure.
    J Clin Exp Hepatol. 2022; 12: S11-S12
    View in Article

    • Google Scholar
79. • Ginès P.
    • Schrier R.W.
    Renal Failure in Cirrhosis.
    N Engl J Med. 2009; 361: 1279-1290
    View in Article

    • Google Scholar
80. • Angeli P.
    • Garcia-Tsao G.
    • Nadim M.K.
    • et al.
    News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document.
    J Hepatol. 2019; 71: 811-822
    View in Article

    • Google Scholar
81. • Rajakumar A.
    • Appuswamy E.
    • Kaliamoorthy I.
    • et al.
    Renal dysfunction in cirrhosis: critical care management.
    Indian J Crit Care Med. 2021; 25: 207-214
    View in Article

    • Google Scholar
82. • Ginès A.
    • Escorsell A.
    • Ginès P.
    • et al.
    Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
    Gastroenterology. 1993; 105: 229-236
    View in Article

    • Google Scholar
83. • Caregaro L.
    • Menon F.
    • Angeli P.
    • et al.
    Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis.
    Arch Intern Med. 1994; 154: 201-205
    View in Article

    • Google Scholar
84. • Kulkarni A.V.
    • Premkumar M.
    • Reddy D.N.
    • et al.
    The challenges of ascites management: an Indian perspective.
    Clin Liver Dis (Hoboken). 2022; 19: 234-238
    View in Article

    • Google Scholar
85. • Kulkarni A.V.
    • Ravikumar S.T.
    • Tevethia H.
    • et al.
    Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.
    Sci Rep. 2022; 12: 5503
    View in Article

    • Google Scholar
86. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.
    J Hepatol. 2018; 69: 406-460
    View in Article

    • Google Scholar
87. • Wong F.
    • Pappas S.C.
    • Reddy K.R.
    • et al.
    Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure.
    Aliment Pharmacol Ther. 2022; 56: 1284-1293
    View in Article

    • Google Scholar
88. • Kulkarni A.V.
    • Kumar P.
    • Rao N.P.
    • et al.
    Terlipressin-induced ischaemic skin necrosis.
    BMJ Case Rep. 2020; 13: e233089
    View in Article

    • Google Scholar
89. • Mackle I.J.
    • Swann D.G.
    • Cook B.
    One year outcome of intensive care patients with decompensated alcoholic liver disease.
    Br J Anaesth. 2006; 97: 496-498
    View in Article

    • Google Scholar
90. • Williams R.
    • Aspinall R.
    • Bellis M.
    • et al.
    Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.
    Lancet. 2014; 384: 1953-1997
    View in Article

    • Google Scholar
91. • Kelly E.M.
    • James P.D.
    • Murthy S.
    • et al.
    Health Care Utilization and Costs for Patients With End-Stage Liver Disease Are Significantly Higher at the End of Life Compared to Those of Other Decedents.
    Clin Gastroenterol Hepatol. 2019; 17: 2339-23346.e1
    View in Article

    • Google Scholar
92. • Gola A.
    • Davis S.
    • Greenslade L.
    • et al.
    Economic analysis of costs for patients with end stage liver disease over the last year of life.
    BMJ Support Palliat Care. 2015; 5: 110
    View in Article

    • Google Scholar
93. • Hudson B.E.
    • Ameneshoa K.
    • Gopfert A.
    • et al.
    Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention.
    Frontline Gastroenterol. 2017; 8: 45-52
    View in Article

    • Google Scholar
94. • Bergenholtz H.
    • Weibull A.
    • Raunkiær M.
    Supportive and palliative care indicators tool (SPICT™) in a Danish healthcare context: translation, cross-cultural adaptation, and content validation.
    BMC Palliat Care. 2022; 21: 41
    View in Article

    • Google Scholar
95. • Kim S.
    • Lee K.
    • Kim C.
    • et al.
    How do we start palliative care for patients with end-stage liver disease?.
    Gastroenterol Nurs. 2022; 45: 101-112
    View in Article

    • Google Scholar
96. • Rogal S.S.
    • Hansen L.
    • Patel A.
    • et al.
    AASLD practice guidance: palliative care and symptom-based management in decompensated cirrhosis.
    Hepatology. 2022; 76: 819-853
    View in Article

    • Google Scholar
97. • Potosek J.
    • Curry M.
    • Buss M.
    • et al.
    Integration of palliative care in end-stage liver disease and liver transplantation.
    J Palliat Med. 2014; 17: 1271-1277
    View in Article

    • Google Scholar
98. • Mehtani R.
    • Premkumar M.
    • Kulkarni A.V.
    Nutrition in Critical Care Hepatology.
    Curr Hepatol Rep. 2022;
    View in Article

    • Google Scholar